Since its approval in 2017 for diabetes, Ozempic has gained widespread attention for a notable side effect: weight loss
Research chemical semaglutide is something else entirely
Originally developed for type 2 diabetes, it has shown strong results in clinical studies for people who want a personalized weight loss program without the need for weight loss surgery
(2) P B Johansen, K T Hansen, J V Andersen, N L Johansen (1998) Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption Xenobiotica, 1998 Nov, Volume 28 (Issue 11), Pages 1083-92
Which raises a fundamental question that patients are increasingly asking: Is GLP-1 without blood work actually safe
More on the trial: medscape.com/viewarticle/ca Interesting findings from the SURMOUNT-MAINTAIN trial on tirzepatide and weight management